Use of Subclavian Extracorporeal Carbon Dioxide Removal for COVID-19 Acute Respiratory Distress Syndrome as a Bridge to Lung Transplantation.
Kha DinhBindu AkkantiManish PatelRahat HussainSukhdeep BasraIgor D GregoricBiswajit KarPublished in: ASAIO journal (American Society for Artificial Internal Organs : 1992) (2023)
Severe acute hypercapnia is independently associated with increased adverse effects and intensive care unit mortality in mechanically ventilated patients. During the severe acute respiratory syndrome coronavirus 2 (COVID-19) pandemic, some patients were placed on extracorporeal carbon dioxide removal support when extracorporeal membrane oxygenation (ECMO) support was at capacity or not offered. We present a patient with severe acute respiratory distress syndrome caused by COVID-19 pneumonia, who was supported with Hemolung Respiratory Assist System (ALung Technologies, Inc., LivaNova, Pittsburgh, PA) via the right subclavian vein as a bridge to lung transplantation after venovenous ECMO support. The patient survived and was discharged home.
Keyphrases
- extracorporeal membrane oxygenation
- acute respiratory distress syndrome
- mechanical ventilation
- carbon dioxide
- respiratory failure
- intensive care unit
- sars cov
- respiratory syndrome coronavirus
- coronavirus disease
- ejection fraction
- prognostic factors
- type diabetes
- case report
- healthcare
- early onset
- cardiovascular events
- patient reported outcomes
- risk factors
- patient reported